Complete and durable regression of leptomeningeal involvement during lorlatinib treatment in a patient with lung cancer
2024 · Anti-Cancer Drugs · 2 citations
https://doi.org/10.1097/cad.0000000000001637
E
E. Martinelli
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
21
Papers
94
Citations
4
h-index
2
i10-index
E. Martinelli is an academic researcher from University of Modena and Reggio Emilia. The author has contributed to research in topics: Colorectal Cancer Treatments and Studies & Lung Cancer Treatments and Mutations & Cancer Genomics and Diagnostics. The author has an h-index of 4, co-authored 18 publications.
ORCID: 0009-0003-5386-2827Papers by this author
worksNeratinib and the Role of Anti‐<scp>HER2</scp> Therapy in Salivary Duct Carcinoma
2025 · Cancer Reports · 1 citations
https://doi.org/10.1002/cnr2.70065
SA12 Encorafenib in Combination With Cetuximab for BRAFV600E-Mutant Metastatic Colorectal Cancer: A Pooled Analysis of European Observational Studies
2024 · Value in Health · 0 citations
https://doi.org/10.1016/j.jval.2024.10.3093
38P Real-world use of encorafenib + cetuximab (EC) in patients with BRAFV600E-mutant metastatic colorectal cancer (mCRC): A pooled analysis of European observational studies
2025 · Annals of Oncology · 0 citations
https://doi.org/10.1016/j.annonc.2025.05.050
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat